This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

GE Healthcare's proposal to acquire Intelerad triggers Australia review

( January 21, 2026, 06:46 GMT | Official Statement) -- MLex Summary: Medical technology company GE Healthcare Technologies’ plan to acquire medical imaging software provider Intelerad will be reviewed by the Australian antitrust regulator. In a statement on Wednesday, the Australian Competition & Consumer Commission said GE Healthcare is a global medical technology, pharmaceutical diagnostics and digital solutions company and has a portfolio of enterprise imaging products for healthcare providers. The statement added that Intelerad is a global medical imaging-software provider that “specializes in diagnostic viewing, reporting, archiving, and collaboration tools for healthcare providers.”Statement follows. Questionnaire is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections